The global Cancer Treatment Drugs market size was valued at US$ 217600 million in 2024 and is forecast to a readjusted size of USD 385110 million by 2031 with a CAGR of 8.6% during review period.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
This report is a detailed and comprehensive analysis for global Cancer Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cancer Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Cancer Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
麻豆原创 segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Major players covered
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Treatment Drugs, with price, sales quantity, revenue, and global market share of Cancer Treatment Drugs from 2020 to 2025.
Chapter 3, the Cancer Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cancer Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Treatment Drugs.
Chapter 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Cancer Treatment Drugs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy
1.3.5 Hormonal Therapy (Biologic Therapy)
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Cancer Treatment Drugs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory or Lung Cancer
1.4.7 Others
1.5 Global Cancer Treatment Drugs 麻豆原创 Size & Forecast
1.5.1 Global Cancer Treatment Drugs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cancer Treatment Drugs Sales Quantity (2020-2031)
1.5.3 Global Cancer Treatment Drugs Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cancer Treatment Drugs Product and Services
2.1.4 Roche Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cancer Treatment Drugs Product and Services
2.2.4 Novartis Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Novartis Recent Developments/Updates
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Treatment Drugs Product and Services
2.3.4 Celgene Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Celgene Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Product and Services
2.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Cancer Treatment Drugs Product and Services
2.5.4 Amgen Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Amgen Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Cancer Treatment Drugs Product and Services
2.6.4 Johnson & Johnson Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Treatment Drugs Product and Services
2.7.4 Pfizer Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Pfizer Recent Developments/Updates
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Cancer Treatment Drugs Product and Services
2.8.4 Takeda Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Takeda Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Cancer Treatment Drugs Product and Services
2.9.4 Eli Lilly Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Cancer Treatment Drugs Product and Services
2.10.4 AstraZeneca Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Cancer Treatment Drugs Product and Services
2.11.4 Astellas Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Astellas Recent Developments/Updates
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Cancer Treatment Drugs Product and Services
2.12.4 Merck & Co. Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Merck & Co. Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Cancer Treatment Drugs Product and Services
2.13.4 Sanofi Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Sanofi Recent Developments/Updates
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Cancer Treatment Drugs Product and Services
2.14.4 Bayer Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Bayer Recent Developments/Updates
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Cancer Treatment Drugs Product and Services
2.15.4 Biogen Idec Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Biogen Idec Recent Developments/Updates
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Cancer Treatment Drugs Product and Services
2.16.4 Eisai Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Eisai Recent Developments/Updates
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Cancer Treatment Drugs Product and Services
2.17.4 Teva Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Teva Recent Developments/Updates
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Cancer Treatment Drugs Product and Services
2.18.4 Otsuka Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Otsuka Recent Developments/Updates
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Cancer Treatment Drugs Product and Services
2.19.4 Merck KGaA Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Merck KGaA Recent Developments/Updates
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Cancer Treatment Drugs Product and Services
2.20.4 Ipsen Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 Ipsen Recent Developments/Updates
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Cancer Treatment Drugs Product and Services
2.21.4 AbbVie Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 AbbVie Recent Developments/Updates
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Cancer Treatment Drugs Product and Services
2.22.4 Gilead Sciences Cancer Treatment Drugs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.22.5 Gilead Sciences Recent Developments/Updates
3 Competitive Environment: Cancer Treatment Drugs by Manufacturer
3.1 Global Cancer Treatment Drugs Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cancer Treatment Drugs Revenue by Manufacturer (2020-2025)
3.3 Global Cancer Treatment Drugs Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Cancer Treatment Drugs by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Cancer Treatment Drugs Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Cancer Treatment Drugs Manufacturer 麻豆原创 Share in 2024
3.5 Cancer Treatment Drugs 麻豆原创: Overall Company Footprint Analysis
3.5.1 Cancer Treatment Drugs 麻豆原创: Region Footprint
3.5.2 Cancer Treatment Drugs 麻豆原创: Company Product Type Footprint
3.5.3 Cancer Treatment Drugs 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cancer Treatment Drugs 麻豆原创 Size by Region
4.1.1 Global Cancer Treatment Drugs Sales Quantity by Region (2020-2031)
4.1.2 Global Cancer Treatment Drugs Consumption Value by Region (2020-2031)
4.1.3 Global Cancer Treatment Drugs Average Price by Region (2020-2031)
4.2 North America Cancer Treatment Drugs Consumption Value (2020-2031)
4.3 Europe Cancer Treatment Drugs Consumption Value (2020-2031)
4.4 Asia-Pacific Cancer Treatment Drugs Consumption Value (2020-2031)
4.5 South America Cancer Treatment Drugs Consumption Value (2020-2031)
4.6 Middle East & Africa Cancer Treatment Drugs Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
5.2 Global Cancer Treatment Drugs Consumption Value by Type (2020-2031)
5.3 Global Cancer Treatment Drugs Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
6.2 Global Cancer Treatment Drugs Consumption Value by Application (2020-2031)
6.3 Global Cancer Treatment Drugs Average Price by Application (2020-2031)
7 North America
7.1 North America Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
7.2 North America Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
7.3 North America Cancer Treatment Drugs 麻豆原创 Size by Country
7.3.1 North America Cancer Treatment Drugs Sales Quantity by Country (2020-2031)
7.3.2 North America Cancer Treatment Drugs Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
8.2 Europe Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
8.3 Europe Cancer Treatment Drugs 麻豆原创 Size by Country
8.3.1 Europe Cancer Treatment Drugs Sales Quantity by Country (2020-2031)
8.3.2 Europe Cancer Treatment Drugs Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cancer Treatment Drugs 麻豆原创 Size by Region
9.3.1 Asia-Pacific Cancer Treatment Drugs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cancer Treatment Drugs Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
10.2 South America Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
10.3 South America Cancer Treatment Drugs 麻豆原创 Size by Country
10.3.1 South America Cancer Treatment Drugs Sales Quantity by Country (2020-2031)
10.3.2 South America Cancer Treatment Drugs Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cancer Treatment Drugs 麻豆原创 Size by Country
11.3.1 Middle East & Africa Cancer Treatment Drugs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cancer Treatment Drugs Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Cancer Treatment Drugs 麻豆原创 Drivers
12.2 Cancer Treatment Drugs 麻豆原创 Restraints
12.3 Cancer Treatment Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Cancer Treatment Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cancer Treatment Drugs
13.3 Cancer Treatment Drugs Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cancer Treatment Drugs Typical Distributors
14.3 Cancer Treatment Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
听
听
*If Applicable.
